US FDA partners with Medicare & Medicaid to promote common evaluation
This article was originally published in Scrip
Executive Summary
The US Food and Drug Administration has signed an agreement with the Centers for Medicare and Medicaid Services to enhance information sharing between the agencies. The agreement would satisfy their common needs for evaluating the safety, efficacy, utilisation, coverage, payment and clinical benefit of drugs, biologics and medical devices.